Cargando…
Associations of Multiparametric Breast MRI Features, Tumor-Infiltrating Lymphocytes, and Immune Gene Signature Scores Following a Single Dose of Trastuzumab in HER2-Positive Early-Stage Breast Cancer
SIMPLE SUMMARY: Imaging biomarkers that permit non-invasive, real-time monitoring of the tumor microenvironment could serve a critical role to facilitate treatment personalization, particularly in the context of new immunotherapies. The aim of this prospective pilot study was to investigate the valu...
Autores principales: | Kennedy, Laura C., Kazerouni, Anum S., Chau, Bonny, Biswas, Debosmita, Alvarez, Rebeca, Durenberger, Grace, Dintzis, Suzanne M., Stanton, Sasha E., Partridge, Savannah C., Gadi, Vijayakrishna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486523/ https://www.ncbi.nlm.nih.gov/pubmed/37686613 http://dx.doi.org/10.3390/cancers15174337 |
Ejemplares similares
-
Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer Patients
por: Gu, Stephanie, et al.
Publicado: (2023) -
The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer Vaccines
por: Gordon, Benjamin, et al.
Publicado: (2020) -
Therapeutic Effect of Trastuzumab in Neoadjuvant-Treated HER2-Positive Breast Cancer with Low Infiltrating Level of Tumor-Infiltrating Lymphocytes
por: Liu, Shiwei, et al.
Publicado: (2020) -
Targeting HER2 in breast cancer: beyond trastuzumab
por: Winer, EP
Publicado: (2011) -
Characterizing Trastuzumab-Induced Alterations in Intratumoral Heterogeneity with Quantitative Imaging and Immunohistochemistry in HER2+ Breast Cancer
por: Syed, Anum K., et al.
Publicado: (2018)